文献速递主动脉疾病

EVAR术后1年瘤囊扩张与晚期死亡独立相关

Aneurysm sac expansion is independently associated with late mortality in patients treated with endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2017-08-31

基于新英格兰血管研究组(VSGNE)2003–2011年注册数据,2437例EVAR患者中1802例有完整1年随访资料。1年时9%瘤囊扩张、52%回缩、39%稳定;

要点

  • EVAR术后1年瘤囊增大≥5 mm虽不常见(9%),但独立增加晚期死亡风险(HR 1.5)。
  • 1年瘤囊回缩≥5 mm与较低晚期死亡风险独立相关(HR 0.6)。
  • 瘤囊扩张患者5年生存率68%,低于其他患者的83%。

核心结论

  • EVAR术后1年腹主动脉瘤囊直径增加至少5 mm虽不常见,但无论是否合并内漏,均独立与晚期死亡相关,值得密切观察并可能早期干预。

研究设计与样本

  • 回顾性队列研究,使用新英格兰血管研究组(VSGNE)2003–2011年注册数据,纳入2437例EVAR患者中有完整1年CT随访资料的1802例(74%)。
  • 瘤囊扩张定义为增大≥5 mm,瘤囊回缩定义为减小≥5 mm,依据血管外科学会(SVS)指南。
  • 采用多变量方法评估瘤囊直径变化的预测因素及瘤囊行为对长期死亡率的影响。

主要发现

  • 1年时162例(9%)瘤囊扩张,709例(39%)瘤囊稳定,931例(52%)瘤囊回缩。

关键数值与推荐

  • 瘤囊扩张定义为EVAR术后1年CT随访时瘤囊直径增大≥5 mm。
  • 瘤囊回缩定义为EVAR术后1年CT随访时瘤囊直径减小≥5 mm。

临床怎么用

  • EVAR术后1年应通过CT随访评估瘤囊直径变化,增大≥5 mm者需密切观察并考虑早期干预。
  • 瘤囊扩张患者即使无内漏,也应视为晚期死亡高风险人群加强随访。
  • 术前肾功能不全、急诊修复、髂内动脉覆盖及随访内漏是瘤囊扩张的预测因素,应针对性关注。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients undergoing endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms can exhibit variations in sac behavior ranging from complete regression to expansion. We evaluated the impact of sac behavior at 1-year follow-up on late survival. METHODS: We used the Vascular Study Group of New England (VSGNE) registry from 2003 to 2011 to identify EVAR patients with 1-year computed tomography follow-up. Aneurysm sac enlargement ≥5 mm (sac expansion) and decrease ≥5 mm (sac regression) were defined per Society for Vascular Surgery guidelines. Predictors of change in sac diameter and impact of sac behavior on long-term mortality were assessed by multivariable methods. RESULTS: Of 2437 patients who underwent EVAR, 1802 (74%) had complete 1-year follow-up data and were included in the study. At 1 year, 162 (9%) experienced sac expansion, 709 (39%) had a stable sac, and 931 (52%) experienced sac regression. Sac expansion was associated with preoperative renal insufficiency (odds ratio [OR], 3.4; 95% confidence interval [CI], 1.5-8.0; P < .01), urgent repair (OR, 2.7; 95% CI, 1.4-5.1; P < .01), hypogastric coverage (OR, 1.7; 95% CI, 1.1-2.7; P = .02), and type I/III (OR, 16.8; 95% CI, 7.3-39.0; P < .001) or type II (OR, 2.9; 95% CI, 2.0-4.3; P < .001) endoleak at follow-up, and sac expansion was inversely associated with smoking (OR, 0.6; 95% CI, 0.4-0.96; P = .03) and baseline aneurysm diameter (OR, 0.7; 95% CI, 0.6-0.9; P < .001). Sac regression (vs expansion or stable sac) was associated with female gender (OR, 1.8; 95% CI, 1.4-2.4; P < .001) and larger baseline aneurysm diameter (OR, 1.4; 95% CI, 1.2-1.5; P < .001) and inversely associated with type I/III (OR, 0.2; 95% CI, 0.1-0.5; P < .01) or type II endoleak at follow-up (OR, 0.2; 95% CI, 0.2-0.3; P < .001). After risk-adjusted Cox regression, sac expansion was independently associated with late mortality (hazard ratio, 1.5; 95% CI, 1.1-2.0; P = .01), even with adjustment for reinterventions and endoleak during follow-up. Sac regression was associated with lower late mortality (hazard ratio, 0.6; 95% CI, 0.5-0.7; P < .001). Long-term survival was lower (log-rank, P < .001) in patients with sac expansion (98% 1-year and 68% 5-year survival) compared with all others (99% 1-year and 83% 5-year survival). CONCLUSIONS: These data suggest that an abdominal aortic aneurysm sac diameter increase of at least 5 mm at 1 year, although infrequent, is independently associated with late mortality regardless of the presence or absence of endoleak and warrants close observation and perhaps early intervention.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Deery SE, Ergul EA, Schermerhorn ML, et al. Aneurysm sac expansion is independently associated with late mortality in patients treated with endovascular aneurysm repair. J Vasc Surg. 2017. PMID: 28865980. doi:10.1016/j.jvs.2017.06.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。